These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28138036)

  • 21. Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.
    Bharadwaj U; Eckols TK; Xu X; Kasembeli MM; Chen Y; Adachi M; Song Y; Mo Q; Lai SY; Tweardy DJ
    Oncotarget; 2016 May; 7(18):26307-30. PubMed ID: 27027445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.
    Bu LL; Zhao ZL; Liu JF; Ma SR; Huang CF; Liu B; Zhang WF; Sun ZJ
    Oncotarget; 2015 Dec; 6(39):41944-58. PubMed ID: 26556875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.
    Jia L; Song Q; Zhou C; Li X; Pi L; Ma X; Li H; Lu X; Shen Y
    PLoS One; 2016; 11(1):e0147157. PubMed ID: 26784960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
    Yun MR; Choi HM; Kang HN; Lee Y; Joo HS; Kim DH; Kim HR; Hong MH; Yoon SO; Cho BC
    Oncogene; 2018 Jan; 37(3):377-388. PubMed ID: 28945228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC.
    Nakamura Y; Togashi Y; Nakahara H; Tomida S; Banno E; Terashima M; Hayashi H; de Velasco MA; Sakai K; Fujita Y; Okegawa T; Nutahara K; Hamada S; Nishio K
    Mol Cancer Ther; 2016 Aug; 15(8):1988-97. PubMed ID: 27207775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
    Chakravarti N; Myers JN; Aggarwal BB
    Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.
    Sun S; Wu Y; Guo W; Yu F; Kong L; Ren Y; Wang Y; Yao X; Jing C; Zhang C; Liu M; Zhang Y; Zhao M; Li Z; Wu C; Qiao Y; Yang J; Wang X; Zhang L; Li M; Zhou X
    Clin Cancer Res; 2018 Jun; 24(11):2665-2677. PubMed ID: 29540490
    [No Abstract]   [Full Text] [Related]  

  • 31. Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas.
    Li M; Ding X; Zhang Y; Li X; Zhou H; Yang L; Li Y; Yang P; Zhang X; Hu J; Nice E; Wu H; Xu H
    Cell Death Dis; 2020 Aug; 11(8):672. PubMed ID: 32826863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis.
    Zhang C; Hao Y; Sun Y; Liu P
    J Pharmacol Sci; 2019 Jun; 140(2):128-136. PubMed ID: 31257059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.
    Datta J; Smith A; Lang JC; Islam M; Dutt D; Teknos TN; Pan Q
    Oncogene; 2012 Sep; 31(36):4045-53. PubMed ID: 22158047
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Anisuzzaman AS; Haque A; Wang D; Rahman MA; Zhang C; Chen Z; Chen ZG; Shin DM; Amin AR
    Mol Cancer Ther; 2017 Apr; 16(4):729-738. PubMed ID: 28119490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC.
    Fan TF; Bu LL; Wang WM; Ma SR; Liu JF; Deng WW; Mao L; Yu GT; Huang CF; Liu B; Zhang WF; Sun ZJ
    Oncotarget; 2015 Dec; 6(41):43581-93. PubMed ID: 26561201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5.
    Sun X; Xiao D; Xu T; Yuan Y
    Future Oncol; 2016 Dec; 12(23):2701-2712. PubMed ID: 27513190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
    Li Z; Zhu T; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Guo W; Wang Y; Jing C; Dong J; Zhou J; Zhang L; Shen Q; Zhou X
    Am J Cancer Res; 2019; 9(4):699-713. PubMed ID: 31105997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.
    Wang Y; Guo W; Li Z; Wu Y; Jing C; Ren Y; Zhao M; Kong L; Zhang C; Dong J; Shuang Y; Sun S; Chen J; Wu C; Qiao Y; Qu X; Wang X; Zhang L; Jin R; Zhou X
    Int J Oncol; 2018 Apr; 52(4):1149-1164. PubMed ID: 29532870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.